Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at BMO Capital Markets from $64.00 to $22.00. They now have an "outperform" rating on the stock.
Q32 Bio Inc. (NASDAQ: QTTB) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Q32 Bio Inc. (NASDAQ: QTTB) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Q32 Bio Inc. (NASDAQ: QTTB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $20.00. They now have an "outperform" rating on the stock.
Q32 Bio Inc. (NASDAQ: QTTB) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $22.00 price target on the stock, down previously from $90.00.